Transcription factor NFAT, its role in cancer development, and as a potential target for chemoprevention

Current Cancer Drug Targets

Volumn 7, Issue 4, 2007, Pages 343-353

  Lu, Haitian ^a   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcineurin; Cancer; Chemoprevention; Gene expression; NFAT; Signaling pathway

Indexed keywords

BINDING PROTEIN; CALCINEURIN; CARCINOGEN; CYCLOSPORIN A; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; PROTEIN INHIBITOR; TACROLIMUS; TRANSCRIPTION FACTOR NFAT;

ANGIOGENESIS; CANCER; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; DRUG INTERACTION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; IMMUNE SYSTEM; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER;

ANIMALS; CARCINOGENS; CHEMOPREVENTION; HUMANS; NEOPLASMS; NFATC TRANSCRIPTION FACTORS;

EID: 34249816810     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907780809750     Document Type: Review

References (106)

1. Lu, H.; Ouyang, W.; Huang, C. Inflammation, a key event in cancer development. Mol. Cancer Res. 2006, 4, 1-13.
2. Rincon, M.; Flavell, R. A. Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell. Biol. 1997, 17 , 1522-1534.
3. Viola, J. P. B.; Carvalho, L. D. S.; Fonseca, B. P. F.; Teixeira, L. K. NFAT transcription factors: from cell cycle to tumor development. Braz. J. Med. Biol. Res. 2005, 38 , 335-344.
4. López-Rodríguez, C.; Aramburu, J.; Rakeman, A. S.; Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl. Acad. Sci. USA 1999, 96 , 7214-7219.
5. Macian, F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 2005, 5, 472-484.
6. Hogan, P. G.; Chen, L.; Nardone, J.; Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003, 17 , 2205-2232.
7. Rao, A.; Luo, C.; Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15 , 707-747.
8. Li, H.; Rao, A.; Hogan, P. G. Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. J. Mol. Biol. 2004, 342, 1659-1674.
9. Rodríguez, A.; Martínez-Martínez, S.; López-Maderuelo, M. D.; Ortega-Pérez, I.; Redondo, J. M. The linker region joining the catalytic and the regulatory domains of CnA is essential for binding to NFAT. J. Biol. Chem. 2005, 280, 9980-9984.
10. Okamura, H.; Aramburu, J.; García-Rodríguez, C.; Viola, J. P.; Raghavan, A.; Tahiliani, M.; Zhang, X.; Qin, J.; Hogan, P. G.; Rao, A. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 2000, 6, 539-550.
11. Martínez-Martínez, S.; Rodríguez, A.; López-Maderuelo, M. D.; Ortega-Pérez, I.; Vázquez, J.; Redondo, J. M. Blockade of NFAT activation by the second calcineurin binding site. J. Biol. Chem. 2006, 281, 6227-6235.
12. Terui, Y.; Saad, N.; Jia, S.; McKeon, F.; Yuan, J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 2004, 279, 28257-28265.
13. Porter, C. M.; Havens, M. A.; Clipstone, N. A. Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J. Biol. Chem. 2000, 275, 3543-3551.
14. Neal, J. W.; Clipstone, N. A. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 2001, 276, 3666-3673.
15. Timmerman, L. A.; Clipstone, N. A.; Ho, S. N.; Northrop, J. P.; Crabtree, G. R. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 1996, 383, 837-840.
16. Gómez del Arco, P.; Martínez-Martínez, S.; Maldonado, J. L.; Ortega-Pérez, I.; Redondo, J. M. A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J. Biol. Chem. 2000, 275, 13872-13878.
17. Yang, T. T.; Xiong, Q.; Enslen, H.; Davis, R. J.; Chow, C. W. Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 2002, 22 , 3892-3904.
18. Beals, C. R.; Sheridan, C. M.; Turck, C. W.; Gardner, P.; Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997, 275, 1930-1934.
19. Gwack, Y.; Sharma, S.; Nardone, J.; Tanasa, B.; Iuga, A.; Srikanth, S.; Okamura, H.; Bolton, D.; Feske, S.; Hogan, P. G.; Rao, A. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature, 2006, 441(7093), 646-650.
20. Liu, W.; Youn, H. D.; Zhou, X. Z.; Lu, K. P.; Liu, J. O. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cistrans isomerase Pin1. FEBS Lett. 2001, 496, 105-108.
21. Willingham, A. T.; Orth, A. P.; Batalov, S.; Peters, E. C.; Wen, B. G.; Aza-Blanc, P.; Hogenesch, J. B.; Schultz, P. G. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 2005, 309, 1570-1573.
22. Wu, W.; Misra, R. S.; Russell, J. Q.; Flavell, R. A.; Rincón, M.; Budd, R. C. Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3. J. Biol. Chem 2006, 281(16), 10682-10690.
23. Stroud, J.; Chen, L. Structure of NFAT bound to DNA as a monomer. J. Mol. Biol. 2003, 334, 1009-1022.
24. Jin , L.; Sliz, P.; Chen, L.; Macian, F.; Rao, A.; Hogan, P. G.; Harrison, S. C. An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site. Nature Struct. Biol. 2003, 10 , 807-811.
25. Chang, C. P.; Neilson, J. R.; Bayle, J. H.; Gestwicki, J. E.; Kuo, A.; Stankunas, K.; Graef, I. A.; Crabtree, G. R. A field of myocardial-endocardial NFAT signalling underlies heart valve morphogenesis. Cell 2004, 118, 649-663.
26. Ho, I. C.; Hodge, M. R.; Rooney, J. W.; Glimcher, L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996, 85 , 973-983.
27. Rengarajan, J.; Mowen, K. A.; McBride, K. D.; Smith, E. D.; Singh, H.; Glimcher, L. H. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 2002, 195, 1003-1012.
28. Decker, E. L.; Nehmann, N.; Kampen, E.; Eibel, H.; Zipfel, P. F.; Skerka, C. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 2003, 31 , 911-921.
29. Nemer, G.; Nemer, M. Cooperative interaction between GATA5 and NFATc regulates endothelial-endocardial differentiation of cardiogenic cells. Development 2002, 129, 4045-4055.
30. Wada, H.; Hasegawa, K.; Morimoto, T.; Kakita, T.; Yanazume, T.; Abe, M.; Sasayama, S. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J. Cell Biol. 2002, 156, 983-991.
31. Macián, F.; García-Rodríguez, C.; Rao, A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 2000, 19 , 4783-4795.
32. Ranger, A. M.; Grusby, M. J.; Hodge, M. R.; Gravallese, E. M.; Charles de la Brousse, F.; Hoey, T.; Mickanin, C.; Baldwin, H. S.; Glimcher, L. H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392, 186-190.
33. Crabtree, G. R.; Olson, E. N. NFAT signalling: choreographing the social lives of cells. Cell 2002, 109(Suppl.), S67-S79.
34. Horsley, V.; Pavlath, G. K. NFAT: ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 2002, 156, 771-774.
35. de la Pompa, J. L.; Timmerman, L. A.; Takimoto, H.; Yoshida, H.; Elia, A. J.; Samper, E.; Potter, J.; Wakeham, A.; Marengere, L.; Langille, B. L.; Crabtree, G. R.; Mak, T. W. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998, 392, 182-186.
36. Schulz, R. A.; Yutzey, K. E. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev. Biol. 2004, 266, 1-16.
37. Hove, J. R.; Köster, R. W.; Forouhar, A. S.; Acevedo-Bolton, G.; Fraser, S. E.; Gharib, M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 421, 172-177.
38. Johnson, E. N.; Lee, Y. M.; Sander, T. L.; Rabkin, E.; Schoen, F. J.; Kaushal, S.; Bischoff, J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J. Biol. Chem. 2003, 278, 1686-1692.
39. Chang, C. P.; Neilson, J. R.; Bayle, J. H.; Gestwicki, J. E.; Kuo, A.; Stankunas, K.; Graef, I. A.; Crabtree, G. R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118, 649-663.
40. Abbott, K. L.; Friday, B. B.; Thaloor, D.; Murphy, T. J.; Pavlath, G. K. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell 1998, 9, 2905-2916.
41. Delling, U.; Tureckova, J.; Lim, H. W.; De Windt, L. J.; Rotwein, P.; Molkentin, J. D. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol. Cell. Biol. 2000, 20 , 6600-6611.
42. -/- mice leads to decreased muscle size in the adult. Dev. Biol. 2001, 232, 115-126.
43. Horsley, V.; Friday, B. B.; Matteson, S.; Kegley, K. M.; Gephart, J.; Pavlath, G. K. Regulation of the growth of multinucleated muscle cells by an NFATc2-dependent pathway. J. Cell Biol. 2001, 153, 329-338.
44. Horsley, V.; Jansen, K. M.; Mills, S. T.; Pavlath, G. K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003, 113, 483-494.
45. Horsley, V.; Pavlath, G. K. Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 2003, 161, 111-118.
46. 2+-dependent calcineurin signaling pathway. Nature 1999, 400, 576-581.
47. Takayanagi, H.; Kim, S.; Koga, T.; Nishina, H.; Isshiki, M.; Yoshida, H.; Saiura, A.; Isobe, M.; Yokochi, T.; Inoue, J. I.; Wagner, E. F.; Mak, T. W.; Kodama, T.; Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3, 889-901.
48. Ishida, N.; Hayashi, K.; Hoshijima, M.; Ogawa, T.; Koga, S.; Miyatake, Y.; Kumegawa, M.; Kimura, T.; Takeya, T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 2002, 277, 41147-41156.
49. Ikeda, F.; Nishimura, R.; Matsubara, T.; Tanaka, S.; Inoue, J. I.; Reddy, S. V.; Hata, K.; Yamashita, K.; Hiraga, T.; Watanabe, T.; Kukita, T.; Yoshioka, K.; Rao, A.; Yoneda, T. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 2004, 114, 475-484.
50. Komarova, S. V.; Pereverzev, A.; Shum, J. W.; Sims, S. M.; Dixon, S. J. Convergent signaling by acidosis and receptor activator of NF-κB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc. Natl. Acad. Sci. USA 2005, 102, 2643-2648.
51. Koga, T.; Matsui, Y.; Asagiri, M.; Kodama, T.; de Crombrugghe, B.; Nakashima, K.; Takayanagi, H. NFAT and osterix cooperatively regulate bone formation. Nat. Med. 2005, 11 , 880-885.
52. Lu, H.; Shi, X.; Costa, M.; Huang, C. Carcinogenic effect of nickel compounds. Mol. Cell. Biochem. 2005, 279, 45-67.
53. Huang, C.; Mattjus, P.; Ma, W. Y.; Rincon, M.; Chen, N. Y.; Brown, R. E.; Dong, Z. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice. J. Biol. Chem. 2000, 275, 9143-9149.
54. Yan, Y.; Li, J.; Ouyang, W.; Ma, Q.; Hu, Y.; Zhang, D.; Ding, J.; Qu, Q.; Subbaramaiah, K.; Huang, C. NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells. J. Cell Sci. 2006, 119(Pt 14), 2985-2994.
55. Duque, J.; Fresno, M.; Iniguez, M. A. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells. J. Biol. Chem. 2005, 289, 8686-8693.
56. Jimenez, J. L.; Iniguez, M. A.; Munoz-Fernández, M. A.; Fresno, M. Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes. Cell Signal. 2004, 16 , 1363-1373.
57. Jiang, H.; Yamamoto, S.; Nishikawa, K.; Kato, R. Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. Carcinogenesis 1993, 14 , 67-71.
58. Singh, R. K.; Gutman, M.; Reich, R.; Bar-Eli, M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 1995, 55 , 3669-3674.
59. Holzmann, K.; Kohlhammer, H.; Schwaenen, C.; Wessendorf, S.; Kestler, H. A.; Schwoerer, A.; Rau, B.; Radlwimmer, B.; Döhner, H.; Lichter, P.; Gress, T.; Bentz, M. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res. 2004, 64 , 4428-4433.
60. Huang, C.; Li, J.; Costa, M.; Zhang, Z.; Leonard, S. S.; Castranova, V.; Vallyathan, V.; Ju, G.; Shi, X. Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res. 2001, 61 , 8051-8057.
61. Li, J.; Huang, B.; Shi, X.; Castranova, V.; Vallyathan, V.; Huang, C. Involvement of hydrogen peroxide in asbestos-induced NFAT activation. Mol. Cell. Biochem. 2002, 234/235, 161-168.
62. Yarosh, D. B.; Pena, A. V.; Nay, S. L.; Canning, M. T.; Brown, D. A. Calcineurin inhibitors decreases DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J. Invest. Dermatol. 2005, 125, 1020-1025.
63. Mazière, C.; Morlière, P.; Louandre, C.; Conte, M. A.; Gomilla, C.; Santus, R.; Antonicelli, F.; Hornebeck, W.; Mazière, J. C. Low UVA doses activates the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway. Free Radic. Biol. Med. 2005, 39 , 1629-1637.
64. Huang, C.; Ke, Q.; Costa M.; Shi, X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem., 2004, 255, 57-66.
65. Colburn, N. H.; Smith, B. M.; Wendel, E. J.; Dowjat, W. K.; Shimada, T. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells. Cancer Res. 1988, 48 , 1195-1200.
66. Yu, C. Y.; Wang, L.; Khaletskiy, A.; Farrar, W. L.; Larner, A.; Colburn, N. H.; Li, J. J. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells. Oncogene 2002, 21 , 3949-3960.
67. Albert R. E.; Miller, M. L.; Cody, T.; Andringa, A.; Shukla, R.; Baxter, C. S. Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis 1991, 12 , 1273-1280.
68. Ouyang, W.; Hu, Y.; Li J.; Ding, M.; Lu, Y.; Zhang, D.; Yan, Y.; Song, L.; Qu, Q.; Desai, D.; Amin, S.; Huang, C. Direct Evidence for the Critical Role of NFAT3 in Benzo[a]pyrene Diol-Epoxide-Induced Cell Transformation through Mediation of Inflammatory Cytokine TNFa in Mouse Epidermal Cl41 Cells. Carcinogenesis, revised.
69. Li, J.; Lu, H.; Huang, C. NFAT3 is required for EGF-induced COX-2 transcription, but neither iNOS transcription nor cell transformation in Cl 41 Cells. Mol. Cell. Biochem. 2006, 289(1-2), 73-82.
70. Li, J.; Song, L.; Zhang, D.; Wei, L.; Huang, C. Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells. J. Cell. Biochem., 2006, 99 (4), 1010-1020.
71. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H. Nitric oxide does not mediate but inhibits transformation and cancer phenotype. Mol. Cancer Ther. 2003, 2, 1285-1293.
72. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100, 57-70.
73. WAF1/CIP1 expression in keratinocyte differentiation. Proc. Natl. Acad. Sci. USA 2001, 98 , 9575-9580.
74. Mammucari, C.; di Vignano, A. T.; Sharov, A. A.; Neilson, J.; Havrda, M. C.; Roop, D. R.; Botchkarev, V. A.; Crabtree, G. R.; Dotto, G. P. Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation. Dev. Cell 2005, 8, 665-676.
75. Baksh, S.; Widlund, H. R.; Frazer-Abel, A. A.; Du, J.; Fosmire, S.; Fisher, D. E.; DeCaprio, J. A.; Modiano, J. F.; Burakoff, S. J. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 2002, 10 , 1071-1081.
76. Sherr, C. J.; Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13 , 1501-1512.
77. Caetano, M. S.; Vieira-de-Abreu, A.; Teixeira, L. K.; Werneck, M. B. F.; Barcinski, M. A.; Viola, J. P. B. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J. 2002, 16 , 1940-1942.
78. Ranger, A. M.; Hodge, M. R.;Gravallese, E. M.; Oukka, M.; Davidson, L.; Alt, F. W.; Charles de la Brousse, F.; Hoey, T.; Grusby, M.; Glimcher, L. H. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 1998, 8, 125-134.
79. Yoshida, H.; Nishina, H.; Takimoto, H.; Marengere, L. E.; Wakeham, A. C.; Bouchard, D.; Kong, Y. Y.; Ohteki, T.; Shahinian, A.; Bachmann, M.; Ohashi, P. S.; Penninger, J. M.; Crabtree, G. R.; Mak, T. W. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998, 8, 115-124.
80. Neal, J. W.; Clipstone, N. A. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 2003, 278, 17246-17254.
81. Chuvpilo, S.; Jankevics, E.; Tyrsin, D.; Akimzhanov, A.; Moroz, D.; Jha, M. K.; Schulze-Luehrmann, J.; Santner-Nanan, B.; Feoktistova, E.; König, T.; Avots, A.; Schmitt, E.; Berberich-Siebelt, F.; Schimpl, A.; Serfling, E. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 2002, 16 , 881-895.
82. Jayanthi, S.; Deng, X.; Ladenheim, B.; McCoy, M. T.; Cluster, A.; Cai, N. S.; Cadet, J. L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 2005, 102, 868-873.
83. Rivera, A.; Maxwell, S. A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 2005, 280, 29346-29354.
84. Mosieniak, G.; Figiel, I.; Kaminska, B. Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. J. Neurochem. 1997, 68 , 1142-1149.
85. Pham, L. V.; Tamayo, A. T.; Yoshimura, L. C.; Lin-Lee, Y. C.; Ford, R. J. Constitutive NF-κB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005, 106, 3940-3947.
86. Fu, L.; Lin-Lee, Y. C.; Pham, L. V.; Tamayo, A.; Yoshimura, L.; Ford, R. J. Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B cell lymphomas. Blood in press.
87. Oukka, M.; Ho, I. C.; Charles de la Brousse, F.; Hoey, T.; Grusby, M. J.; Glimcher, L. H. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 1998, 9, 295-304.
88. Hernández, G. L.; Volpert, O. V.; Íniguez, M. A.; Lorenzo, E.; Martínez-Martínez, S.; Grau, R.; Fresno, M.; Redondo, J. M. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase-2. J. Exp. Med. 2001, 193, 607-620.
89. Bouck, N.; Stellmach, V.; Hsu, S. C. How tumors become angiogenic. Adv. Cancer Res. 1996, 69 , 135-174.
90. Zaichuk, T. A.; Shroff, E. H.; Emmanuel, R.; Filleur, S.; Nelius, T.; Volpert, O. V. Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J. Exp. Med. 2004, 199, 1513-1522.
91. Volpert, O. V.; Zaichuk, T. A.; Zhou, W.; Reiher, F.; Ferguson, T. A.; Stuart, P. M.; Amin, M.; Bouck, N. P. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 2002, 8, 349-357.
92. Sporn, M. B. The war on cancer. Lancet 1996, 347, 1377-1381.
93. Jauliac, S.; López-Rodriguez, C.; Shaw, L. M.; Brown, L. F.; Rao, A.; Toker, A. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol. 2002, 4, 540-544.
94. Yoeli-Lerner, M.; Yiu, G. K.; Rabinovitz, I.; Erhardt, P.; Jauliac, S.; Toker, A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 2005, 20 , 539-550.
95. Yiu, G. K.; Toker, A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 2006, 281(18), 12210-12217.
96. Lee, H.; Chouinard, L.; Bonin, M.; Michel, R. N. NFATc3 deficiency may contribute to the development of mammary gland adenocarcinoma in aging female mice. Mol. Carcinogen. 2005, 44 , 219-222.
97. Glud, S. Z.; Sorensen, A. B.; Andrulis, M.; Wang, B.; Kondo, E.; Jessen, R.; Krenacs, L.; Stelkovics, E.; Wabl, M.; Serfling, E.; Palmetshofer, A.; Pedersen, F. S. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 2005, 106, 3546-3552.
98. Ranger, A. M.; Gerstenfeld, L. C.; Wang, J.; Kon, T.; Bae, H.; Gravallese, E. M.; Glimcher, M. J.; Glimcher, L. H. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 2000, 191, 9-22.
99. Xanthoudakis, S.; Viola, J. P.; Shaw, K. T.; Luo, C.; Wallace, J. D.; Bozza, P. T.; Luk, D. C.; Curran, T.; Rao, A. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 1996, 272, 892-895.
100. Hodge, M. R.; Ranger, A. M.; Charles de la Brousse, F.; Hoey, T.; Grusby, M. J.; Glimcher, L. H. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 1996, 4, 397-405.
101. Roehrl, M. H. A.; Kang, S.; Aramburu, J.; Wagner, G.; Rao, A.; Hogan, P. G. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc. Natl. Acad. Sci. USA 2004, 101, 7554-7559.
102. Kiani, A.; Rao, A.; Aramburu, J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000, 12 , 359-372.
103. Venkatesh, N.; Feng, Y.; DeDecker, B.; Yacono, P.; Golan, D.; Mitchison, T.; McKeon, F. Chemical genetics to identify FNAT inhibitors: potential of targeting calcium mobilization in immunosuppression. Proc. Nat. Acad. Sci. USA 2004, 101, 8969-8974.
104. Aramburu, J.; García-Cozár, F.; Raghavan, A.; Okamura, H.; Rao, A.; Hogan, P. G. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1998, 1, 627-637.
105. Aramburu, J.; Yaffe, M. B.; López-Rodríguez, C.; Cantley, L. C.; Hogan, P. G.; Rao, A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999, 285, 2129-2133.
106. Kang, S.; Li, H.; Rao, A.; Hogan, P. G. Inhibition of the calcineurin-NFAT interaction by small organic molecules reflects binding at an allosteric site. J. Biol. Chem. 2005, 280, 37698-37706.